|
|
|
Volumn 23, Issue 5 SUPPL. 11, 1996, Pages 6-10
|
|
Single-agent paclitaxel as first-line treatment of metastatic breast cancer: The British experience
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COLONY STIMULATING FACTOR;
PACLITAXEL;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
BREAST METASTASIS;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
HORMONAL THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RELAPSE;
SURVIVAL TIME;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARCINOMA;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
GREAT BRITAIN;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
NEURITIS;
PACLITAXEL;
PREMENOPAUSE;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
SURVIVAL RATE;
|
|
EID: 0029826227
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|
